But Opko is also determined to go into oncology, infectious diseases, and neurological disorders.

FORBES: Teva Chairman Continues To Seek Undervalued Biopharmaceuticals

But they are also quietly determined that things will not go back to the way they were.

BBC: News | UK | Prosperity at stake